Target intelligence / Profile preview

Multiple inflammatory and immune-related protein targets

Molecular classification
Other
01

Overview

Multiple inflammatory and immune-related protein targets refers to a broad and heterogeneous group of molecular entities that mediate the body's response to injury and pathogens. This category encompasses various classes of proteins, including cytokines like Tumor Necrosis Factor (TNF) and Interleukins (IL-1, IL-6, IL-17, IL-23), as well as intracellular signaling molecules such as Janus Kinases (JAKs) (Source: StatPearls, "Inflammation"). These proteins play critical roles in orchestrating both innate and adaptive immune responses, and their chronic overactivation is a hallmark of autoimmune and autoinflammatory diseases (Source: Nature Reviews Drug Discovery, "Targeting cytokines in inflammation"). Drugs targeting these proteins, such as monoclonal antibodies and small molecule inhibitors, are widely used to treat conditions like rheumatoid arthritis, Crohn's disease, and psoriasis. However, because this term describes a collection of targets rather than a single specific molecule, it is considered a functional grouping rather than a distinct therapeutic target.

Other names
Inflammatory targetsImmune-related targetsPro-inflammatory mediatorsInflammatory signaling proteins
02

Mechanism of action

Various mechanisms including cytokine neutralization, receptor antagonism, and intracellular signaling inhibition.

03

Biological functions

Immune responseInflammationSignal transductionCell-cell signaling
04

Disease associations

InflammationAutoimmune diseaseInfectionCancer
05

Safety considerations

ImmunosuppressionIncreased risk of opportunistic infectionsPotential for malignancyInfusion or injection site reactions
06

Biomarkers

C-reactive proteinErythrocyte sedimentation ratePro-inflammatory cytokine levels (e.g., TNF, IL-6)

Beyond the preview

Go deeper on Multiple inflammatory and immune-related protein targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple inflammatory and immune-related protein targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call